Updated June 27, 2007
Georgia Firm Secures $7M in New Financing to Battle Cellulite
Post a comment
Print this storyE-mail story
Share
DULUTH, Ga. —
Cellutions, a startup focused on medical devices and procedures to treat cellulite, has closed on $7 million in new funding, according to VentureWire.
The company, which was formed in 2004, landed Versant Ventures as a new investor. Existing investors Carlyle Venture partners and SV Life Sciences also participated.
Cellutions raised a $5.6 million Series A round for proof of concept and feasibility studies.
According to the firm’s Web site, cellulite affects 90 percent of post-adolescent females. Its proposed technology and procedure would be performed on an outpatient basis in what the company calls a “lunchtime” treatment.
Featured
Hot Off The Wire
- Hot Off the Wire – Maryland firm BroadSoft files for IPO; Twitter preps China page; John Grisham’s Firm, other titles now e-books
- Hot Off the Wire – Apple charges $107 for iPad batteries; Amazon drops Colorado affiliates like it did in N.C.; Facebook expands in India
- Hot Off the Wire – $5M bonus for Apple exec; Disney to shut studio, cut 450 jobs; Motorola co-CEO’s pay $3.77M; Adobe CEO pay plunges 68%

